Published in Brain Res on August 16, 2008
Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res (2010) 1.83
Whole-exome sequencing identifies OR2W3 mutation as a cause of autosomal dominant retinitis pigmentosa. Sci Rep (2015) 1.49
Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc Natl Acad Sci U S A (2009) 1.49
Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J Psychiatr Res (2013) 1.20
Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry (2012) 1.15
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat Rev Genet (2015) 1.14
In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr Res (2009) 1.12
Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis (2011) 1.11
Control of interneuron dendritic growth through NRG1/erbB4-mediated kalirin-7 disinhibition. Mol Psychiatry (2011) 1.09
Genome-wide expression profiling of schizophrenia using a large combined cohort. Mol Psychiatry (2012) 1.06
Kalirin loss results in cortical morphological alterations. Mol Cell Neurosci (2009) 1.01
Normal human aging and early-stage schizophrenia share common molecular profiles. Aging Cell (2009) 0.99
Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders. Transl Psychiatry (2011) 0.97
Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia. Mol Brain (2014) 0.96
Kalrn plays key roles within and outside of the nervous system. BMC Neurosci (2012) 0.95
Active DNA demethylation in post-mitotic neurons: a reason for optimism. Neuropharmacology (2013) 0.94
The neurobiology and treatment of first-episode schizophrenia. Mol Psychiatry (2014) 0.93
Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines. Cytoskeleton (Hoboken) (2012) 0.93
The centrosomal E3 ubiquitin ligase FBXO31-SCF regulates neuronal morphogenesis and migration. PLoS One (2013) 0.92
Meta-analysis of gene coexpression networks in the post-mortem prefrontal cortex of patients with schizophrenia and unaffected controls. BMC Neurosci (2013) 0.90
Kalirin, a key player in synapse formation, is implicated in human diseases. Neural Plast (2012) 0.90
Hippocampal phenotypes in kalirin-deficient mice. Mol Cell Neurosci (2010) 0.89
Prefrontal cortical dysfunction after overexpression of histone deacetylase 1. Biol Psychiatry (2013) 0.89
'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared. Neurogenetics (2014) 0.88
Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. Front Cell Neurosci (2013) 0.87
Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia. Bipolar Disord (2014) 0.86
Epigenetic mechanisms in schizophrenia. Dialogues Clin Neurosci (2014) 0.85
Neuregulin1 signaling promotes dendritic spine growth through kalirin. J Neurochem (2013) 0.85
Dystrophic serotonin axons in postmortem brains from young autism patients. Anat Rec (Hoboken) (2011) 0.84
Differential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophrenia. Psychiatry Res (2012) 0.83
Regional and duration of illness differences in the alteration of NCAM-180 mRNA expression within the cortex of subjects with schizophrenia. Schizophr Res (2009) 0.82
Long-term perturbation of spine plasticity results in distinct impairments of cognitive function. J Neurochem (2012) 0.80
Profile of minocycline and its potential in the treatment of schizophrenia. Neuropsychiatr Dis Treat (2014) 0.79
Bridging the Gap between Genes and Language Deficits in Schizophrenia: An Oscillopathic Approach. Front Hum Neurosci (2016) 0.79
Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment. Front Neurosci (2016) 0.79
Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. Front Psychiatry (2015) 0.79
Antipsychotics activate the TGFβ pathway effector SMAD3. Mol Psychiatry (2012) 0.79
Ablation of ErbB4 from excitatory neurons leads to reduced dendritic spine density in mouse prefrontal cortex. J Comp Neurol (2014) 0.79
Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia. Transl Psychiatry (2016) 0.78
Validating reference genes using minimally transformed qpcr data: findings in human cortex and outcomes in schizophrenia. BMC Psychiatry (2016) 0.78
SZDB: A Database for Schizophrenia Genetic Research. Schizophr Bull (2017) 0.78
Increased co-expression of genes harboring the damaging de novo mutations in Chinese schizophrenic patients during prenatal development. Sci Rep (2015) 0.77
Meta-analysis of sex differences in gene expression in schizophrenia. BMC Syst Biol (2016) 0.77
Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning. Mol Psychiatry (2017) 0.76
Expression of HDAC2 but Not HDAC1 Transcript Is Reduced in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia. ACS Chem Neurosci (2016) 0.76
Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue. Transl Psychiatry (2016) 0.76
Schizophrenia as segmental progeria. J R Soc Med (2011) 0.76
Low Density Lipoprotein Receptor-Related Protein and Apolipoprotein E Expression is Altered in Schizophrenia. Front Psychiatry (2010) 0.76
Dissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers. Schizophr Res Treatment (2011) 0.76
Protein Interaction Networks Link Schizophrenia Risk Loci to Synaptic Function. Schizophr Bull (2016) 0.75
Serial mitogen-stimulated cytokine production from continuously ill patients with schizophrenia. Neuropsychopharmacology (2010) 0.75
Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies. Transl Psychiatry (2017) 0.75
Increased cortical expression of the zinc transporter SLC39A12 suggests a breakdown in zinc cellular homeostasis as part of the pathophysiology of schizophrenia. NPJ Schizophr (2016) 0.75
Autophagy and Schizophrenia: A Closer Look at How Dysregulation of Neuronal Cell Homeostasis Influences the Pathogenesis of Schizophrenia. Einstein J Biol Med (2016) 0.75
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med (2005) 28.99
Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics (2006) 22.61
Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol (2001) 15.02
Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci (2005) 11.68
A global test for groups of genes: testing association with a clinical outcome. Bioinformatics (2004) 10.82
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A (2001) 6.68
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84
CoREST: a functional corepressor required for regulation of neural-specific gene expression. Proc Natl Acad Sci U S A (1999) 4.59
Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron (2000) 4.29
Regulation of neuronal traits by a novel transcriptional complex. Neuron (2001) 4.02
A web-based tool for principal component and significance analysis of microarray data. Bioinformatics (2005) 3.42
Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry (2007) 2.91
Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry (2002) 2.43
Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry (2005) 2.41
Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry (2003) 2.39
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12
Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry (2001) 2.02
Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology (2007) 1.98
Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull (2001) 1.97
The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry (2001) 1.94
Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci (2002) 1.79
Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res (2002) 1.76
Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry (1999) 1.73
Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry (2006) 1.66
A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull (1988) 1.65
Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry (2007) 1.58
Neurocognitive impairment across the lifespan in schizophrenia: an update. Schizophr Res (2005) 1.56
Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr Res (2005) 1.52
Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am J Psychiatry (2003) 1.46
Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease. J Neurochem (2006) 1.46
Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull (2001) 1.44
Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am J Psychiatry (2001) 1.43
Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Res (2007) 1.39
Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol Psychiatry (1999) 1.36
Genome wide gene expression studies in mood disorders. OMICS (2006) 1.35
Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. Am J Psychiatry (2007) 1.33
The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry (2006) 1.28
A long-term follow-up study of schizophrenia: psychiatric course of illness and prognosis. Acta Psychiatr Scand (1975) 1.24
Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry (2002) 1.20
Problem of diagnosis in postmortem brain studies of schizophrenia. Am J Psychiatry (1996) 1.17
Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res (2004) 1.17
Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia. Aust N Z J Psychiatry (2007) 1.13
A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr Res (2001) 1.12
Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia. Int J Neuropsychopharmacol (2007) 1.12
Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. Int J Neuropsychopharmacol (2007) 1.12
Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning. Neurobiol Aging (1993) 1.05
The course of functional decline in geriatric patients with schizophrenia: cognitive-functional and clinical symptoms as determinants of change. Am J Geriatr Psychiatry (2003) 1.05
RE1 Silencing transcription factor maintains a repressive chromatin environment in embryonic hippocampal neural stem cells. Stem Cells (2006) 1.05
Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist (2006) 1.05
Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression. Ann N Y Acad Sci (2004) 1.03
The Maine and Vermont three-decade studies of serious mental illness. II. Longitudinal course comparisons. Br J Psychiatry (1995) 1.02
Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders. Mol Neurobiol (2006) 0.97
Understanding structural brain changes in schizophrenia. Dialogues Clin Neurosci (2006) 0.93
Neurobiology and the natural history of schizophrenia. J Clin Psychiatry (2006) 0.91
Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study. Psychiatry Clin Neurosci (2001) 0.91
Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. Int Rev Neurobiol (2005) 0.90
Neurocognitive function in schizophrenia at a 10-year follow-up: a preliminary investigation. CNS Spectr (2005) 0.90
The profiles of clinical deterioration in schizophrenia. J Psychiatr Res (1998) 0.85
Natural history of schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. Arch Gen Psychiatry (1991) 0.83
Long-term follow-up of patients hospitalized for schizophrenia, 1913 to 1940. J Nerv Ment Dis (1997) 0.79
Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. II. Causal-analytical investigations. Eur Arch Psychiatry Neurol Sci (1989) 0.79
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci (2010) 3.11
Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc Natl Acad Sci U S A (2008) 2.43
The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice. Proc Natl Acad Sci U S A (2008) 2.37
Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant (2004) 2.35
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant (2004) 2.17
Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability. Cell Stem Cell (2010) 2.02
Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem (2002) 2.00
The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy. Hum Mol Genet (2007) 1.95
Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis (2009) 1.89
Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin. J Bacteriol (2006) 1.85
Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res (2010) 1.83
Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: implications for Alzheimer's disease. J Neurosci Res (2011) 1.80
The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A (2013) 1.78
Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One (2012) 1.70
Cortical glutamatergic markers in schizophrenia. Neuropsychopharmacology (2005) 1.67
Developmental control of a lepidopteran pest Spodoptera exigua by ingestion of bacteria expressing dsRNA of a non-midgut gene. PLoS One (2009) 1.51
A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. Glycobiology (2005) 1.49
Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease. J Neurochem (2006) 1.46
8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur J Pharmacol (2004) 1.40
Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol (2003) 1.39
Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr Bull (2008) 1.37
Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins. J Immunol (2007) 1.34
Activation of murine CD4+ and CD8+ T lymphocytes leads to dramatic remodeling of N-linked glycans. J Immunol (2006) 1.34
Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res (2006) 1.34
5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol Psychiatry (2005) 1.34
Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo. J Neurochem (2009) 1.34
Targeted disruption of RC3 reveals a calmodulin-based mechanism for regulating metaplasticity in the hippocampus. J Neurosci (2002) 1.33
Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells. Microbes Infect (2010) 1.33
Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma. Invest Ophthalmol Vis Sci (2006) 1.30
Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci (2004) 1.30
Directional RNA deep sequencing sheds new light on the transcriptional response of Anabaena sp. strain PCC 7120 to combined-nitrogen deprivation. BMC Genomics (2011) 1.29
Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems. Hum Mol Genet (2012) 1.24
Quantitative bias in Illumina TruSeq and a novel post amplification barcoding strategy for multiplexed DNA and small RNA deep sequencing. PLoS One (2011) 1.24
Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease. Neurobiol Dis (2012) 1.23
Illumina mate-paired DNA sequencing-library preparation using Cre-Lox recombination. Nucleic Acids Res (2011) 1.22
A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia. Biol Psychiatry (2005) 1.20
The relationship between the rate of molecular evolution and the rate of genome rearrangement in animal mitochondrial genomes. J Mol Evol (2006) 1.18
MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes. J Immunol (2011) 1.18
Localization of Smc5/6 to centromeres and telomeres requires heterochromatin and SUMO, respectively. EMBO J (2008) 1.16
CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology (2012) 1.16
Mice lacking 5-HT receptors show specific impairments in contextual learning. Eur J Neurosci (2004) 1.15
The hypocretins and sleep. FEBS J (2005) 1.15
Noncoding transcription within the Igh distal V(H) region at PAIR elements affects the 3D structure of the Igh locus in pro-B cells. Proc Natl Acad Sci U S A (2012) 1.14
The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol (2006) 1.13
Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia. Aust N Z J Psychiatry (2007) 1.13
Rad3 decorates critical chromosomal domains with gammaH2A to protect genome integrity during S-Phase in fission yeast. PLoS Genet (2010) 1.11
Genome-wide identification of Bcl11b gene targets reveals role in brain-derived neurotrophic factor signaling. PLoS One (2011) 1.11
Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett (2012) 1.10
Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease. Neurobiol Dis (2008) 1.09
Helicobacter pylori induces beta3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x. J Clin Invest (2008) 1.09
Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia. Biol Psychiatry (2007) 1.09
Modulatory effects of estrogen and progesterone on colorectal hyperalgesia in the rat. Pain (2005) 1.08
Reciprocal patterns of methylation of H3K36 and H3K27 on proximal vs. distal IgVH genes are modulated by IL-7 and Pax5. Proc Natl Acad Sci U S A (2008) 1.08
Removal of Pb(II) from aqueous solution on chitosan/TiO(2) hybrid film. J Hazard Mater (2008) 1.07
Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. Future Microbiol (2010) 1.07
Gene expression profiling of R6/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's disease. Neurobiol Dis (2011) 1.07
Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet (2006) 1.07
Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis. Science (2011) 1.06
Regulated and aberrant glycosylation modulate cardiac electrical signaling. Proc Natl Acad Sci U S A (2009) 1.05
Glycogene expression in conjunctiva of patients with dry eye: downregulation of Notch signaling. Invest Ophthalmol Vis Sci (2008) 1.04
Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia? J Neurochem (2008) 1.03
Differential transcriptome analysis of glandular and filamentous trichomes in Artemisia annua. BMC Plant Biol (2013) 1.03
A single dose mass balance study of the Hedgehog pathway inhibitor vismodegib (GDC-0449) in humans using accelerator mass spectrometry. Drug Metab Dispos (2011) 1.02
A review of optical imaging and therapy using nanosized graphene and graphene oxide. Biomaterials (2013) 1.02
The class A chitin synthase gene of Spodoptera exigua: molecular cloning and expression patterns. Insect Biochem Mol Biol (2007) 1.01
Application of microdroplet PCR for large-scale targeted bisulfite sequencing. Genome Res (2011) 1.01
Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical development. Mol Pharm (2013) 1.00
Chronic haloperidol treatment results in a decrease in the expression of myelin/oligodendrocyte-related genes in the mouse brain. J Neurosci Res (2007) 1.00
Evidence for disruption of sphingolipid metabolism in schizophrenia. J Neurosci Res (2009) 0.99
General strategy for fabricating thoroughly mesoporous nanofibers. J Am Chem Soc (2014) 0.99
Normal human aging and early-stage schizophrenia share common molecular profiles. Aging Cell (2009) 0.99
Determination of unbound vismodegib (GDC-0449) concentration in human plasma using rapid equilibrium dialysis followed by solid phase extraction and high-performance liquid chromatography coupled to mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.99
Different functions of the insect soluble and membrane-bound trehalase genes in chitin biosynthesis revealed by RNA interference. PLoS One (2010) 0.99
A rat model of chronic postinflammatory visceral pain induced by deoxycholic acid. Gastroenterology (2008) 0.98
Autophagy protects against oxaliplatin-induced cell death via ER stress and ROS in Caco-2 cells. PLoS One (2012) 0.98
Differences in the neuronal response to food in obesity-resistant as compared to obesity-prone individuals. Physiol Behav (2013) 0.98
Identification of 20-hydroxyecdysone late-response genes in the chitin biosynthesis pathway. PLoS One (2010) 0.97
Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation. Int J Neuropsychopharmacol (2008) 0.97
Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease. Hum Mol Genet (2012) 0.96
In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons. Hum Mol Genet (2010) 0.96
Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia. Int J Neuropsychopharmacol (2012) 0.95
miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc. J Gastroenterol Hepatol (2014) 0.95
Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection. J Neurosci (2006) 0.95
Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain. Synapse (2007) 0.95
Differential processing of noxious colonic input by thoracolumbar and lumbosacral dorsal horn neurons in the rat. J Neurophysiol (2005) 0.94
Assessing a novel room-temperature RNA storage medium for compatibility in microarray gene expression analysis. Biotechniques (2009) 0.94
Galectin-8 induces apoptosis in the CD4(high)CD8(high) thymocyte subpopulation. Glycobiology (2007) 0.94
An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees. Blood (2004) 0.93
A role of apolipoprotein D in triglyceride metabolism. J Lipid Res (2010) 0.93
Brain structure predicts risk for obesity. Appetite (2012) 0.93